ArticleEpidemiology and infection2014
Serovars and antimicrobial resistance of non-typhoidal Salmonella from human patients in Shanghai, China, 2006-2010.
Article in Epidemiology and infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 53 citations in OpenAlex.
- Review
- Prevalence and Antimicrobial Resistance Diversity ofAntibiotics (Basel, Switzerland) · 2024Article
- Epidemiology of Multidrug-ResistantJournal of tropical medicine · 2024Article
- Molecular characterization of IncFII plasmid carryingmSphere · 2023Article
- Genomic analysis of almost 8,000Microbiology spectrum · 2023Article
- Assessing the mechanisms of multi-drug resistant non-typhoidal Salmonella (NTS) serovars isolated from layer chicken farms in Nigeria.PloS one · 2023Article
- Article
- Salmonella serovars in sheep and goats and their probable zoonotic potential to humans in Suez Canal Area, Egypt.Acta veterinaria Scandinavica · 2022Article
- Prevalence of Chromosomally LocatedMicrobiology spectrum · 2022Article
- Serotype Diversity and Antimicrobial Resistance Profile ofFrontiers in veterinary science · 2022Article
- Prevalence and Trends in Antimicrobial Susceptibility Patterns of Multi-Drug-Resistance Non-TyphoidalInfection and drug resistance · 2022Article
- Genomic Characterization ofFrontiers in microbiology · 2022Article
- Pharmacokinetics and Pharmacodynamics of Colistin Combined With Isopropoxy Benzene Guanidine AgainstFrontiers in microbiology · 2022Article
- Heavy Metal Resistance inFrontiers in microbiology · 2021Article
- The phenotypic and molecular characteristics of antimicrobial resistance of Salmonella enterica subsp. enterica serovar Typhimurium in Henan Province, China.BMC infectious diseases · 2020Article
- Epidemiological Study on Prevalence, Serovar Diversity, Multidrug Resistance, and CTX-M-Type Extended-Spectrum β-Lactamases ofAntimicrobial agents and chemotherapy · 2020Article
- Prevalence, Antimicrobial Resistance, Virulence Genes and Genetic Diversity ofMicroorganisms · 2020Article
- A Multidrug-resistant MonophasicInfection and drug resistance · 2020Article
- Fourth Generation Cephalosporin Resistance AmongFrontiers in microbiology · 2020Article
- Emergence and Dissemination ofMicroorganisms · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We conducted a retrospective study on non-typhoidal Salmonella isolates from patients with diarrhoea in Shanghai, China, 2006-2010. A total of 1484 isolates of 70 Salmonella serovars were recovered from about 18 000 stool specimens. Serovars Enteritidis and Typhimurium were the most prevalent with isolation rates of 27.6% and 25.5%, respectively. The majority (1151, 77.6%) of the isolates were resistant to at least one antimicrobial, and 598 (40.3%) to more than three antimicrobials. Approximately half (50.9%) of the isolates were resistant to nalidixic acid and other resistance rates were sulfisoxazole (47.9%), streptomycin (37.6%), ampicillin (31.3%) and tetracycline (30.5%). Co-resistance to fluoroquinolones and the third- and fourth-generation cephalosporins was also identified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.